On the other hand, Dai et al. observed that DAHP treatment (80 mg/kg/day) for two weeks once tumors reached 100 mm3 in size inhibited AKT/eNOS pathway activation and decreased BH4 and NO concentration in hepatocellular carcinoma tissue. This evidence concerns the gene AKT1 and hepatocellular carcinoma.